Search results

Page results

• First participant joins new Parkinson’s Disease study at UCLH

  UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.

• Focus on cancer vaccine trials at UCLH

  Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.

• Managing diabetes at Christmas time

  The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022.

• BCG treatment for bladder cancer

  This information will give you an overview of BCG immunotherapy, how it is given and side effects it may cause.

• Clinical Research Facility at UCLH awarded £10 million

  The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.

• London hospitals partner up to run event for children and young people with sickle cell disorder at the Tottenham Hotspur Stadium

  North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.

• Study looking at whether COVID-19 and flu vaccines can be administered at the same time

  Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.

• NHS Staff Survey 2024 – we’re the top acute trust to work at for third year running!

  Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!

• First participant in Europe joins new myeloma trial at UCLH

  UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.

• UCLH top trust to work at in London – and third best in the country

  Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.